Page last updated: 2024-10-21

phenytoin and Hematologic Diseases

phenytoin has been researched along with Hematologic Diseases in 6 studies

Hematologic Diseases: Disorders of the blood and blood forming tissues.

Research Excerpts

ExcerptRelevanceReference
"Phenobarbital may cause hyperactivity, behavioral problems, sedation, and even dementia; these effects are dose related to some extent."5.27Side effects of phenobarbital and phenytoin during long-term treatment of epilepsy. ( Iivanainen, M; Savolainen, H, 1983)
" VP-16 concentrations were measured in all plasma samples by high-performance liquid chromatography (HPLC) and electrochemical detection, and the results were analyzed with a pharmacokinetic data analysis system."1.29Pharmacokinetics of undiluted or diluted high-dose etoposide with or without busulfan administered to patients with hematologic malignancies. ( Bewermeier, P; Hossfeld, DK; Krüger, W; Mross, K; Stockschläder, M; Zander, A, 1994)
"Phenobarbital may cause hyperactivity, behavioral problems, sedation, and even dementia; these effects are dose related to some extent."1.27Side effects of phenobarbital and phenytoin during long-term treatment of epilepsy. ( Iivanainen, M; Savolainen, H, 1983)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19905 (83.33)18.7374
1990's1 (16.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Iivanainen, M1
Savolainen, H1
Mross, K1
Bewermeier, P1
Krüger, W1
Stockschläder, M1
Zander, A1
Hossfeld, DK1
Pochedly, C1
Ente, G1
Livingston, S1
Pauli, LL1
Reunanen, A1

Reviews

1 review available for phenytoin and Hematologic Diseases

ArticleYear
Adverse hematologic effects of drugs.
    Pediatric clinics of North America, 1972, Volume: 19, Issue:4

    Topics: Anemia, Hemolytic; Anemia, Macrocytic; Anti-Bacterial Agents; Anticonvulsants; Antidepressive Agents

1972

Other Studies

5 other studies available for phenytoin and Hematologic Diseases

ArticleYear
Side effects of phenobarbital and phenytoin during long-term treatment of epilepsy.
    Acta neurologica Scandinavica. Supplementum, 1983, Volume: 97

    Topics: Abnormalities, Drug-Induced; Brain; Dose-Response Relationship, Drug; Drug Tolerance; Endocrine Syst

1983
Pharmacokinetics of undiluted or diluted high-dose etoposide with or without busulfan administered to patients with hematologic malignancies.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1994, Volume: 12, Issue:7

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Child; Chromatography,

1994
Letter: Diphenylhydantoin and blood dyscrasias.
    JAMA, 1974, Oct-14, Volume: 230, Issue:2

    Topics: Epilepsy; Hematologic Diseases; Humans; Phenytoin

1974
[Different adverse effects of phenytoin].
    Duodecim; laaketieteellinen aikakauskirja, 1971, Volume: 87, Issue:11

    Topics: Epilepsy; Hematologic Diseases; Humans; Phenytoin

1971
Carbamazepine (Tegretol).
    The Medical letter on drugs and therapeutics, 1968, Jun-28, Volume: 10, Issue:13

    Topics: Agranulocytosis; Anemia, Aplastic; Blood Platelet Disorders; Carbamazepine; Dibenzazepines; Hematolo

1968